Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
Revenue Increased 17% Quarter over Quarter Operating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., Nov. 14, 2024 (GLOBE NEWSWIRE) -- . (“Vivos” or the ...